ScTIL injection
Sponsors
Chinese Academy of Medical Sciences, Peking University
Conditions
Advanced Tumor of Digestive Tract or Urinary SystemDigestive System Malignant Solid Tumors
Phase 1
A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors
NCT05499715
Start: 2022-09-30End: 2024-08-30Target: 48Updated: 2022-08-12
Phase Ib Clinical Study on the Safety, the Tolerability, the Pharmacokinetics and the Efficacy of ScTIL Injection (Gene Modified Tumor Infiltrating Lymphocytes) Alone and in Combination With B Lymphocyte Adjuvant in the Treatment of Digestive System Malignant Solid Tumors
NCT05730361
Start: 2023-02-28End: 2024-08-31Target: 48Updated: 2023-02-15